So here we would like to discuss the efficacy of platelet-rich plasma (PRP) Treatment - for the treatment of joint damage / cartilage injury, which is commonly characterised by progressive pain and loss of joint function within joint osteoarthritis (OA).
It has been well established that PRP treatment modulates the inflammatory and tissue damage environment through the treatment of high concentrations of platelets, leukocytes, and growth factors. Clinically, PRP treatment has been shown to be possibly a viable treatment option for a variety of inflammatory and degenerative conditions. Recent efforts have focused on optimising a potent biological process which promotes healing and improves the symptoms of degenerative arthritis for a longer duration.
As for the progression of degenerative joint arthritis there are many inclusive factors, including inhibition of inflammatory cells and altering the level of enzymatic expression. PRP therapy specifically aims to modulate inflammation and cell degradation in a degenerative environment through the secretion of anti-inflammatory factors.
There are a growing number of studies that have demonstrated the clinical benefit of PRP treatment for the non-surgical management of degenerative arthritis. As we can appreciate and understand, research takes time but additional blinded randomised controlled trials with long-term follow-ups are currently underway to validate PRP's therapeutic efficacy in this setting. Additionally, contined well-designed pre-clinical studies are underway which will further clarify the effectiveness of PRP in cartilage repair and regeneration.
Here at Dynamic Regenerative Medicine in Solihull and Birmingham we are providing regular treatment for joint pain, joint injury and joint osteoarthritis with conservative and PRP treatments with ongoing success. Get in touch to find out more schedule a FREE consultation.
Further detailed information can be found on the study below: https://www.ncbi.nlm.nih.gov/m/pubmed/30203333/